Another study also confirmed that a single-nucleotide polymorphism within the binding site of miRNA-1827 on the 3’ UTR of MYCL1 could repress the expression level of the latter, triggering the progression of small-cell lung cancer (Xiong et al., 2011). Here, MYCL is linked to small cell lung carcinoma.